Jean-Charles Tschudin, a non-executive director at the skin care products supplier Sinclair Pharma, has added to his holding in the company with the purchase of 56,000 shares at 36p a time.
He now has 967,117 shares, which is about 0.4% of the company.
Top Director Buys
Subscribe to MoneyWeek
Subscribe to MoneyWeek today and get your first six magazine issues absolutely FREE
Sign up to Money Morning
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Don't miss the latest investment and personal finances news, market analysis, plus money-saving tips with our free twice-daily newsletter
Qatar Investment Fund (QIF) Director name: Mr David von SimsonAmount purchased: 75,000 @ $0.93 Value: $69,750
Sinclair Pharma (SPH) Director name: Mr Jean-Charles TschudinAmount purchased: 56,000 @ 36.00p Value: £20,160
Witan Inv Trust (WTAN) Director name: Mr Robert W BoyleAmount purchased: 2,024 @ 525.00p Value: £10,626
Top Director Sells
-
Which investments can I hold in a stocks and shares ISA – and which ones are banned?HMRC has a list stating which investments are allowed in ISAs, but sometimes investors, and even ISA providers, get confused by the rules. Here’s what you need to know when picking your investments.
-
Review: Andronis Minois and Andronis Arcadia – two Greek island idyllsTravel Andronis Minois on Paros and Andronis Arcadia on Santorini are two beautiful, authentic hotels on two different islands in Greece
